Mostrar el registro sencillo del ítem

Accidente cerebrovascular - revisión de la literatura: etiología, diagnóstico, tratamiento general y análisis pediátrico

Accidente cerebrovascular - revisión de la literatura: etiología, diagnóstico, tratamiento general y análisis pediátrico

dc.creatorÁlvarez P., Andrés Mauricio
dc.date2016-08-19
dc.date.accessioned2020-08-21T20:23:18Z
dc.date.available2020-08-21T20:23:18Z
dc.identifierhttps://revistacolombianadeenfermeria.unbosque.edu.co/article/view/1439
dc.identifier10.18270/rce.v6i6.1439
dc.identifier.urihttp://test.repositoriodigital.com:8080/handle/123456789/10579
dc.descriptionEl accidente cerebro vascular y la trombosis venosa cere - bral son patologías de causa significativa de morbilidad y mortalidad en la población adulta y pediátrica en todo el mundo. La incidencia y prevalencia en los Estados Unidos de América es alta dada la deficiencia en hábitos de vida saludable y alta incidencia de patologías de origen genético (1). La presentación clínica en los pacientes pediátricos es diversa y con representación semiológica distinta a los pacientes adultos. En la práctica médica se debe realizar un enfoque multidisciplinario para el tratamiento de la enfermedad cerebro vascular aguda especialmente en pacientes pediátricos, lo cual permitirá el diagnóstico temprano y la disminución de secuelas (2). Por medio de este artículo explicamos cómo los equipos médicos en medicina de urgencias y los planteamientos en salud pública deben ser evaluados, desarrollados y plasmados en el personal de salud para desarrollar un tratamiento rápido y eficaz en el servicio de urgencias en el diagnóstico temprano, por medio de la aplicación multidisciplinaria del plantel con la identificación y análisis oportunos de signos y síntomas del paciente en cualquier edad (1, 2). Los equipos de emergencia de acci - dente vascular deben estar representados por neurólogos, hematólogos con experiencia en trastornos de la coagu - lación, neuro radiólogos y personal con experiencia en la rehabilitación y servicio de terapia intensivista. Es necesario realizar una gestión integral y oportuna en la capacitación y ejercicio del programa de intervención en accidente es-AR
dc.descriptionEl accidente cerebro vascular y la trombosis venosa cere - bral son patologías de causa significativa de morbilidad y mortalidad en la población adulta y pediátrica en todo el mundo. La incidencia y prevalencia en los Estados Unidos de América es alta dada la deficiencia en hábitos de vida saludable y alta incidencia de patologías de origen genético (1). La presentación clínica en los pacientes pediátricos es diversa y con representación semiológica distinta a los pacientes adultos. En la práctica médica se debe realizar un enfoque multidisciplinario para el tratamiento de la enfermedad cerebro vascular aguda especialmente en pacientes pediátricos, lo cual permitirá el diagnóstico temprano y la disminución de secuelas (2). Por medio de este artículo explicamos cómo los equipos médicos en medicina de urgencias y los planteamientos en salud pública deben ser evaluados, desarrollados y plasmados en el personal de salud para desarrollar un tratamiento rápido y eficaz en el servicio de urgencias en el diagnóstico temprano, por medio de la aplicación multidisciplinaria del plantel con la identificación y análisis oportunos de signos y síntomas del paciente en cualquier edad (1, 2). Los equipos de emergencia de acci - dente vascular deben estar representados por neurólogos, hematólogos con experiencia en trastornos de la coagu - lación, neuro radiólogos y personal con experiencia en la rehabilitación y servicio de terapia intensivista. Es necesario realizar una gestión integral y oportuna en la capacitación y ejercicio del programa de intervención es-ES
dc.formatapplication/pdf
dc.languagespa
dc.publisherUniversidad El Bosquees-ES
dc.relationhttps://revistacolombianadeenfermeria.unbosque.edu.co/article/view/1439/1045
dc.relation/*ref*/Rey Pérez A. Emergencias neurológicas. Elsevier España; 2005. pp. 130. 2. Bonduel M, Sciuccati G, Hepner M, Torres AF, Pieroni G, Frontroth JP. Prethrombotic disorders in children with arterial ischemic stroke and sinovenous throm - bosis. Arch Neurol. 1999; 56: 967–971. 3. Braun KP, Bulder MM, Chabrier S, et ál. The course and outcome of unilateral intracranial arteriopathy in 79 children with ischaemic stroke. Brain. 2009; 132: 544-557. 4. Lynch JK, Hirtz DG, DeVeber G, et ál. Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. Pedia - trics. 2002; 109: 116-123. 5. Lanthier S, Carmant L, David M, et ál. Stroke in chil - dren: the coexistence of multiple risk factors predicts poor outcome. Neurology. 2000; 54: 371-378. 6. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO. Ischemic stroke subtypes: a popula - tion-based study of incidence and risk factors. Stroke. 1999; 30: 2513–16. 7. Williams LS, Garg BP, Cohen M, Fleck JD, Biller J. Subtypes of ischemic stroke in children and young adults. Neurology. 1997; 49: 1541–1545. 8. Garcia JH, Ho Khang-Loon, Pantoni L. Pathology in: Barnett, Henry JM, Mohr JP, Stein BM, Yatsu FM (eds), Stroke pathophysiology, diagnosis and management. 3ª ed. Philadelphia, PA: Churchill Livingston; 1998. 9. Accidente cerebrovascular. Neurowikia febrero 22 2011 [en línea]. Disponible en: <http: //www.neurowikia.es/ content/ictus-en-paciente-joven>. 10. Wise RJ, Bernardi S, Frackowiak RS, Legg NJ, Jones T. Serial observations on the pathophysiology of acute stroke: the transition from ischaemia to infarction as reflected in regional oxygen extraction. Brain. 1983; 106 (Pt 1): 197-222. 11. Pediatric Stroke Working Group. Stroke in childhood: clinical guidelines for diagnosis, management and rehabilitation. 2008. Disponible en: <http: //www. rcplondon.ac.uk/pubs/books/childstroke>. 12. Kirkham FJ, Prengler M, Hewes DK, Ganesan V. Risk factors for arterial ischemic stroke in children. J Child Neurol. 2000; 15: 299-307. 13. Amlie-Lefond C, Chan AK, Kirton A, et ál. Thrombolysis in acute childhood stroke: design and challenges of the thrombolysis in pediatric stroke clinical trial. Neuroepi- demiology 2009; 32: 279-286. 14. López-Vicente M, Ortega-Gutierrez S, Amlie-Lefond C, Torbey MT. Diagnosis and menagement of pedi - atric arterial ischemic stroke. J Stroke Cerebrovasc Dis. 2010; 19: 175-183. 15. Garcia JH, Liu K, Yoshida Y, et ál. Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat). Am J Pathol. 1994; 144: 188-199. 16. Toni D, Fiorelli M, Bastianello S, et ál. Hemorrhagic transformation of brain infarct: predictability in the first five hours from stroke onset and influence on clin - ical outcome. Neurology. 1996; 46: 341-345. 17. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr. on Behalf of the American Heart Association Stroke Council. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plas- minogen activator. Stroke 2009; 40: 2945–8. 18. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plas- minogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS study—a randomized controlled trial (alteplase thrombolysis for acute noninterventional therapy in ischemic stroke). JAMA 1999; 282: 2019–26. 19. Hacke W, Kaste M, Fieschi C, et ál. Intravenous throm - bolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the european cooperative acute stroke study (ECASS). JAMA. 1995; 274: 1017–25. 20. The Internet Stroke Center at Washington University in St. Louis. Clearer: Study of the combination therapy of rt-PA and eptifibatide to treat acute ischemic stroke (SPOTRIAS) [en línea] [Consultado en diciembre de 2009]. Disponible en: <http: //www.strokecenter.org/ trials/TrialDetail.aspx?tid=995>. 21. The IMS Study Investigators. Combined intravenous and intraarterial recanalization for acute ischemic stroke: the interventional management of stroke study. Stroke. 2004; 35: 904–11. 22. The IMS II Trial Investigators. The interventional management of stroke (IMS) II study. Stroke. 2007; 38: 2127–35. 23. Gladstone DJ, Black SE, Hakim AM. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke. 2002; 33: 2123– 36. 24. Saver JL, Kidwell C, Eckstein M, Starkman S. Prehos- pital neuroprotective therapy for acute stroke: results of the field administration of stroke therapy– magnesium (FAST-MAG) pilot trial. Stroke. 2004; 35: e106–8. 25. Elkind MS, Flint AC, Sciacca RR, Sacco RL. Lipid- lowering agent use at ischemic stroke onset is associated with decreased mortality. Neurology. 2005; 65: 253–8. 26. Laskowitz DT, Kasner SE, Saver J, Remmel KS, Jauch EC. Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the biomarker rapid assessment in ischemic injury (BRAIN) study. Stroke. 2009; 40: 77–85. 27. Polderman KH, Herold I. Therapeutic hypothermia and controlled normothermia in the intensive care unit: practical considerations, side effects, and cooling methods. Crit Care Med 2009; 37: 1101–20. 28. Challa V. Atherosclerosis of the cervicocranial arteries. In: Toole JF, ed. Cerebrovascular disorders. 5ª ed. Phila - delphia: Lippincott Williams and Wilkins; 1999. 29. Fuster V. Stein B, Amboose JA, et ál. Atherosclerotic plaque rupture and thrombosis: evolving concepts. Circulation. 1990; 82 (supp II); 47-59. 30. Glaglov S, Zarins CB. What are the determinants of plaque instability and its consequences? J Vasc Surg. 198; 9: 389-390. Pathophysiology of Stroke Page 11 of 14 Sid Shah, MD. 31. Falk E. Why do plaques rupture? Circulation. 1992; 86: 30-42. 32. Zamir M, Silver MD. Hemorrhagic and mocrovascular phenomenon within the arterial wall. Can J Cardiol. 1992; 8: 981-84. 33. Pullicino PM. Pathogenesis of lacunar infarcts and small deep infarcts. Adv Neurol. 1993; 62: 125-140. 34. Graf R, Saito R, Hubel K, et ál. Spreading depression- like negativations turn into terminal depolarizations after prolonged focal ischemia in rates. J Cereb Blood Flow Metab. 1995; 15 (supp 1): S15. 35. Rankel MR, et ál. Predicting prognosis after stroke. A placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PAstroke trial. Neurology. 2000; 55: 952-9. 36. Blanco M, Nombela F, Castellanos M, et ál. Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology. 2007; 69: 904–10. 37. Kirkham FJ, Lerner NB, Noetzel M, et ál. Trials in sickle cell disease. Pediatr Neurol 2006; 34: 450-458. 38. Pediatric Stroke Working Group. Stroke in childhood: clinical guidelines for diagnosis, management and rehabilitation, 2004 [en línea] [consultado en febrero de 2011]. Disponible en: <http: //www.rcplondon.ac.uk/ pubs/books/childstroke>. 39. Heros R. Stroke: early pathophysiology and treatment. Stroke. 1994; 25: 1877-1881. 40. Siesjő BK. Cell damage in the brain: a speculative synthesis. J Cereb Blood Flow Metab. 1981; 1: 115-185. 41. Roach ES, Golomb MR, Adams R, et ál. Management of stroke in infants and children: a scientific state - ment from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young.American Heart Association Stroke Council; Council on Cardiovascular Disease in the Young.Stroke. 2009; 40: e8-10. 42. Garcia JH, Liu K, Yoshida Y, et ál. Brain mictrovessels: factors altering their patency after the occlusion of a middle cerebral artery (Wistar rat). Am J Pathol.1994; 145: 728-40. 43. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA.2001; 285: 2486–97. 44. Angelini L, Ravelli A, Caporali R, Rumi V, Nardocci N, Martini A. High prevalence of antiphospholipid anti - bodies in children with idiopathic cerebral ischemia. Pediatrics. 1994; 94: 500–503. 45. Ware RE, Zimmerman SA, Sylvestre PB, et ál. Preven - tion of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy. J Pediatr.2004; 145: 346-352. 46. Hansen AJ. Effects of anoxia on ion distribution in the brain. Physiol Rev. 1985; 65: 101-148. 47. Golomb MR, MacGregor DL, Domi T, et ál. Presumed pre-or perinatal arterial ischemic stroke: risk factors and outcomes.Ann Neurol. 2001; 50: 163–168. 48. Schwab S, Spranger M, Aschoff A, et ál. Brain tempera - ture monitoring and modulation in patients with severe MCA infarction. Neurology.1997; 48: 762-767. 49. Pulsinelli WA. The ischemic penumbra in stroke. Sci Med. 1995; 1: 16-25. 50. DeVeber G, MacGregor D, Curtis R, Mayank S. Neuro - logic outcome in survivors of childhood arterial ischemic stroke and sinovenous thrombosis. J Child Neurol. 2000; 15: 316–324. 51. DeVeber G, Andrew M. Cerebral sinovenous throm - bosis in children. N Engl J Med. 2001; 345: 417–423. 52. Alberts MJ, Latchaw RE, Selman WR, et ál. Recommen - dations for comprehensive stroke centers: a consensus statement from the brain attack coalition. Stroke. 2005; 36: 1597–616. 53. Macgregor D, Shroff M. Presumed perinatal ischemic stroke: vascular classification predicts outcomes. Annals of Neurology, 2008; 63: 436–443. 54. Broderick J, Brott T, Kothari R, et ál. The Greater Cincin - nati/Northern Kentucky Stroke Study. Preliminary first-ever and total incidence rates of stroke among blacks. Stroke.1998; 29: 415–421. 55. Fullerton HJ, Wu YW, Sidney S, et ál. Risk of recurrent childhood arterial ischemic stroke in a population- based cohort: The importance of cerebrovascular imaging. Pediatrics. 2007; 119: 495-501. 56. Gosalakkal JA. Moyamoya disease: a review. Neurol India 2002; 50: 6-10. 57. Husson B, Rodesch G, Lasjaunias P, et ál. Magnetic resonance angiography in childhood arterial brain infarcts: a comparative study with contrast angiog - raphy. Stroke. 2002; 33: 1280-1285. 58. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg.1968; 28: 14-20. 59. Keun-Sik MD, Jeffrey L, et ál. Quantifying the value of stroke disability outcomes. Stroke. 2009; 40: 3828-33. 60. Linfante I, et ál. Diffusion-weighted imaging and National Institutes of Health Stroke Scale in the acute phase of posterior circulation stroke. Arch Neurol. 2001; 58: 621-8. 61. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Med J. 1965: 13: 61-65. 62. Takagi K, Ginsberg MD, Globus MY-T, et ál. Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbral region following middle cerebral artery occlusion in the rat: correlation with histopathology. J Cereb Blood Flow Metab. 1993; 13: 575-585. 63. Back T, Ginsberg MD, Dietrich WD, Watson BD. Induction of spreading depression in the ischemic hemisphere following experimental middle cerebral artery occlusion: effect on infarct morphology. J Cereb Blood Flow Metab. 1996; 16: 202-213. 64. Vahedi K, Hofmeijer J, Juettler E, et ál. Early decom - pressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007; 6: 215–22. 65. Mayer SA, Rincon F. Treatment of intracerebral hemor - rhage. Lancet Neurol 2005; 4: 662–72. 66. The Internet Stroke Center at Washington University in St. Louis.Stroke interventions in clinical trials: Investi - gational drugs—by name [en línea] [consultado el 6 de marzo de 2011]. Disponible en: <http: //www.stroke - center.org/Trials/index_drugs.aspx>. 67. Saver JL, Albers GW, Dunn B, Johnston KC, Fisher M. Stroke therapy academic industry roundtable (STAIR) recommendations for extended window acute stroke therapy trials. Stroke. 2009; 40: 2594–600. 68. Specialized Programs of Translational Research in Acute Stroke (SPOTRIAS) Network [en línea] [consul - tado el 6 de marzo de 2010].Disponible en: <http: // hopecenter.wustl.edu/spotrias/Pages/default.aspx>. 69. Wass CT, Lanier WL. Glucose modulation of ischemic brain injury: review and clinical recommendations. Mayo Clin Proc. 1996; 71: 801-812. 70. Bardutzky J, Schwab S. Antiedema therapy in ischemic stroke. Stroke.2007; 38: 3084–94. 71. Atkinson DS Jr. Computered tomography of pediatric stroke. Semin Ultrasound CT MRT.2006; 27: 207-218. 72. Kim CY, Wang KC, Kim SK, et ál. Encephaloduroarterio - synangiosis with bifrontal encephalogaleo (periosteal) - synangiosis in the pediatric moyamoya disease: the surgical technique and its outcomes. Childs Nerv Syst. 2003; 19: 316-324. 73. Lynch JK. Cerebrovascular disorders in children. Curr Neurol Neurosci Rep. 2004; 4: 129-138. 74. Roach ES, Golomb MR, Adams R, et ál. Management of stroke in infants and children: a scientific state - ment from a special writing group of the American Heart Association stroke council and the council on cardiovascular disease in the young. Stroke. 2008; 39: 2644–91. 75. Gruber A. Interventional management of stroke. Stroke. 2008; 39: 1663–4. 76. National Institute of Neurological Disorders and Stroke.NINDS CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and Leukoen - cephalopathy) [en línea] [consultado en marzo de 2010]. Disponible en: <http: //www.ninds.nih.gov/disorders/ cadasil/CADASIL.htm>. 77. Hacke W, Kaste M, Bluhmki E, et ál for the ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.N Engl J Med. 2008; 359: 1317–29. 78. Foerch C, Montaner J, Furie KL, Ning MM, Lo EH.Invited article: Searching for oracles? Blood biomarkers in acute stroke. Neurology. 2009; 73: 393–9. 79. Reith J, Jorgensen HS, Pedersen PM, et ál. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality and outcome. Lancet. 1996; 347: 422-425. 80. Bruno A, Biller J, Adams HP Jr, et ál. Acute blood glucose level and outcome from ischemic stroke. Neurology. 1999; 52: 280-284. 81. Astrup J, Seisjo BK, Symon L. Thresholds in cerebral ischemia – the ischemic penumbra. Stroke. 1981; 12: 723-725. 82. Pezzini A, Del Zotto E, Giossi A, Volonghi I, Grassi M, Padovani A. The migraine–ischemic stroke connec - tion: potential pathogenic mechanisms. Curr Mol Med. 2009; 9: 215–26. 83. Price DJ. Factors restricting the use of coma scales. Acta Neuro-chir. 1986; 36 (suppl.): 106-111. 84. Stammt JE, Lindffen S. ls it posible to define a general conscious level? Acta Neurochir. 1986; 36 (suppl.): 103-105. 85. Heinemman AW, Harvey RL, McGuire JR, et ál. Measure - ment properties of the NIH Stroke Scale during acute rehabilitation. Stroke. 1997; 28: 1174-80. 86. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974; 2: 81-84. 87. Saver JL, Gornbein J, Grotta J, et ál. Number needed to treat to benefit and to harm for intravenous tissue plas - minogen activator therapy in the 3 to 4.5 hour window: joint outcome table analysis of the ECASS 3 trial. Stroke. 2009; 40: 2433–7 88. Lyden PD, Allgren RL, Ng K, et ál. Intravascular cooling in the treatment of stroke (ICTuS): early clinical experience.J Stroke Cerebrovasc Dis. 2005; 14: 107–14. 89. Wahlgren N, Ahmed N, Davalos A, et ál. Thrombolysis with alteplase 3–4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet. 2008; 372: 1303–9. 90. Zaidat OO, Klucznik R, Alexander MJ. The NIH registry on use of the Wingspan stent for symptomatic 70–99% intracranial arterial stenosis. Neurology. 2008;70: 1518–24. 91. Paciaroni M, Agnelli G, Corea F, et ál. Early hemorrhagic transformation of brain infarction: rate, predictive factors and influence on clinical outcome— Results of a prospective multicenter study. Stroke. 2008; 39: 2249–56. 92. Bershad EM, Feen ES, Hernandez OH, Suri MF, Suarez JI.Impact of a specialized neurointensive care team on outcomes of critically ill acute ischemicstroke patients. Neurocrit Care. 2008; 9: 287–92. 93. Caplan LR. Resolved: heparin may be useful in selected patients with brain ischemia. Stroke. 2003; 34: 230–1. 94. Chamorro A, Vila N, Ascaso C, Blanc R. Heparin in acute stroke with atrial fibrillation: clinical relevance of very early treatment. Arch Neurol. 1999; 56: 1098–102. 95. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians evidence- based clinical practice guidelines, 8th ed. Chest. 2008; 133(6 suppl): S630–69. 96. Demaerschalk BM, Miley ML, Kiernan TE, et ál. Stroke telemedicine. Mayo Clin Proc. 2009; 84: 53–64. 97. Dambinova SA, Khounteev GA, Izykenova GA, Zavo - lokov IG, Ilyukhina AY, Skoromets AA. Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with tran - sient ischemic attack and stroke. Clin Chem. 2003; 49: 1752–62. 98. Guías Americanas Stroke e Hipertensión Arterial[en línea] [consultado en marzo de 2011]. Disponible en: <http: //www.americanheart.org/presenter. jhtml?identifier=4742>. 99. Centers for Disease Control and Prevention. Prehos - pital and hospital delays after stroke onset—United States, 2005–2006.MMWR Morb Mortal Wkly Rep. 2007; 56: 474–8. 100. Lamonte MP, Bahouth MN, Magder LS, et ál. A regional system of stroke care provides thrombolytic outcomes comparable with the NINDS stroke trial. Ann Emerg Med. 2009; 54: 319–27. 101. The Internet Stroke Center at Washington University in St. Louis.Stroke scales and clinical assessment tools [en línea] [consultado en octubre de 2010]. Disponible en: < http: //www.strokecenter.org/trials/ scales/index.htm>. 102. Montaner J, Álvarez-Sabin J. NIH Stroke Scale and its adaptation to Spanish. Neurología. 2006; 21(4): 192-202. 103. Broderick J, Connolly S, Feldmann E, et ál. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update— A guideline from the American Heart Association/American Stroke Association stroke council, high blood pres- sure research council, and the quality of care and outcomes in research interdisciplinary working group. Circulation. 2007;116: e391–413. 104. Potter JF, Robinson TG, Ford GA, et ál. Controlling hypertension and hypotension immediately post- stroke (CHHIPS): a randomised, placebocontrolled, double-blind pilot trial. Lancet Neurol. 2009; 8: 48–56. 105. Accidente cerebro vascular, generalidades y rehabili - tación [en línea] [consultado en noviembre de 2010]. Disponible en: <http: //www.neurowikia.es/content/ introducci%C3%B3n-al-ictus-en-edadpedi%C3%A1
dc.sourceRevista Colombiana de Enfermería; Vol 6 (2011): Revista Colombiana de Enfermería; 102-120en-US
dc.sourceRevista Colombiana de Enfermería; ##issue.vol## 6 (2011): Vol 6, Año 6; 102-120es-AR
dc.sourceRevista Colombiana de Enfermería; Vol. 6 (2011): Revista Colombiana de Enfermería; 102-120es-ES
dc.sourceRevista Colombiana de Enfermería; v. 6 (2011): Revista Colombiana de Enfermería; 102-120pt-BR
dc.source2346-2000
dc.source1909-1621
dc.source10.18270/rce.v6i0
dc.subjectaccidente cerebrovasculares-ES
dc.subjectACVes-ES
dc.subjecthemoraagia cerebrales-ES
dc.subjecthipertención endocraneanaes-ES
dc.subjecttrombosis cerebrales-ES
dc.subjectpediatríaes-ES
dc.subjectrehabilitaciónes-ES
dc.titleAccidente cerebrovascular - revisión de la literatura: etiología, diagnóstico, tratamiento general y análisis pediátricoes-AR
dc.titleAccidente cerebrovascular - revisión de la literatura: etiología, diagnóstico, tratamiento general y análisis pediátricoes-ES
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem